Protalix BioTherapeutics, Inc. (PLX) vs Cartesian Therapeutics, Inc. (RNAC)

Protalix BioTherapeutics, Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Protalix BioTherapeutics, Inc. and Cartesian Therapeutics, Inc. are of similar size ($230.6M and $221.6M). Cartesian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.3×. Protalix BioTherapeutics, Inc. grew revenue faster over the last twelve months: 30.1% against −94.8%. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 17 metrics below, Protalix BioTherapeutics, Inc. leads on 11 and Cartesian Therapeutics, Inc. on 6.